These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas. Leto SM; Sassi F; Catalano I; Torri V; Migliardi G; Zanella ER; Throsby M; Bertotti A; Trusolino L Clin Cancer Res; 2015 Dec; 21(24):5519-31. PubMed ID: 26296355 [TBL] [Abstract][Full Text] [Related]
12. [The RAS paradox of the EGFR-targeted therapy in colorectal cancer]. Tímár J; Láng I Magy Onkol; 2008 Jun; 52(2):185-91. PubMed ID: 18640895 [TBL] [Abstract][Full Text] [Related]
13. New advances in targeted therapies for squamous cell carcinoma of the head and neck. Machiels JP; Schmitz S Anticancer Drugs; 2011 Aug; 22(7):626-33. PubMed ID: 21048493 [TBL] [Abstract][Full Text] [Related]
14. Immune Checkpoint Inhibitors in the Treatment of Gastrointestinal Malignancies: A Review of Current and Future Therapies. Hsu A; Mendelson L; Almhanna K R I Med J (2013); 2020 Apr; 103(3):33-37. PubMed ID: 32236159 [TBL] [Abstract][Full Text] [Related]
15. Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck. Le Tourneau C; Siu LL Curr Opin Oncol; 2008 May; 20(3):256-63. PubMed ID: 18391623 [TBL] [Abstract][Full Text] [Related]
16. Overcoming Resistance to Targeted Therapies in Gastrointestinal Cancers: Progress to Date and Progress to Come. Chen C; Di Bartolomeo M; Corallo S; Strickler JH; Goyal L Am Soc Clin Oncol Educ Book; 2020 May; 40():161-173. PubMed ID: 32421451 [TBL] [Abstract][Full Text] [Related]
17. Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment. Giordani E; Zoratto F; Strudel M; Papa A; Rossi L; Minozzi M; Caruso D; Zaccarelli E; Verrico M; Tomao S Curr Cancer Drug Targets; 2016; 16(2):175-85. PubMed ID: 26278713 [TBL] [Abstract][Full Text] [Related]
18. Optimizing outcomes in HER2-positive breast cancer: the molecular rationale. Esteva FJ; Pusztai L Oncology (Williston Park); 2005 Nov; 19(13 Suppl 5):5-16. PubMed ID: 19364051 [TBL] [Abstract][Full Text] [Related]
19. Predictive and prognostic factors in the complex treatment of patients with colorectal cancer. László L Magy Onkol; 2010 Dec; 54(4):383-94. PubMed ID: 21163770 [TBL] [Abstract][Full Text] [Related]
20. Aquaporins: Their role in gastrointestinal malignancies. Nagaraju GP; Basha R; Rajitha B; Alese OB; Alam A; Pattnaik S; El-Rayes B Cancer Lett; 2016 Apr; 373(1):12-18. PubMed ID: 26780474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]